Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Why Dolby Laboratories (DLB) Could Be Positioned for a Surge

Dolby Laboratories, Inc. DLB is an audio/video production company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on DLB’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Dolby Laboratories could be a solid choice for investors.

Current Quarter Estimates for DLB

In the past 30 days, 4 estimates have gone higher for Dolby Laboratories with no downward revisions in the same time period. The trend has been pretty favorable too, with estimates increasing from 39 cents a share 30 days ago, to 51 today, a move of 30.8%.

Current Year Estimates for DLB

Meanwhile, Dolby Laboratories’s current year figures are also looking quite promising, with 5 estimates moving higher in the past month, compared to no downward revisions. The consensus estimate trend has also seen a boost for this time frame, increasing from $1.57 per share 30 days ago to $1.77 per share today, an increase of 12.7%.

Bottom Line

The stock has also started to move higher lately, adding 5.5% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
DOLBY LAB INC-A (DLB): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research